Talk:Musculoskeletal System - Abnormalities
|About Discussion Pages|
Cite this page: Hill, M.A. (2021, October 26) Embryology Musculoskeletal System - Abnormalities. Retrieved from https://embryology.med.unsw.edu.au/embryology/index.php/Talk:Musculoskeletal_System_-_Abnormalities
FC01.5 Postradiation scoliosis FC01 Postprocedural disorders of the musculoskeletal system
Scoliosis is known not to be limited only to the frontal plane, and can be defined as a three dimensional torsional deformity of the spine and trunk it causes a lateral curvature in the frontal plane, an axial rotation in the horizontal one, and a disturbance of the sagittal plane normal curvatures, kyphosis and lordosis, usually, but not always, reducing them in direction of a flat back. “Structural scoliosis”, or just scoliosis, must be differentiated from “functional scoliosis”, that is a spinal curvature secondary to known extraspinal causes (e.g. shortening of a lower limb or paraspinal muscle tone asymmetry). It is usually partially reduced or completely subsides after the underlying cause is eliminated (e.g. in a recumbent position).
Q67 Congenital musculoskeletal deformities of head, face, spine and chest - Q67.5 Congenital deformity of spine Congenital scoliosis: NOS postural Excl.: infantile idiopathic scoliosis (M41.0) scoliosis due to congenital bony malformation (Q76.3)
- Q65.0 Congenital dislocation of hip, unilateral
- Q65.1 Congenital dislocation of hip, bilateral
- Q65.2 Congenital dislocation of hip, unspecified
- Q65.3 Congenital subluxation of hip, unilateral
- Q65.4 Congenital subluxation of hip, bilateral
- Q65.5 Congenital subluxation of hip, unspecified
- Q65.6 Unstable hip Dislocatable hip Subluxatable hip
- Q65.8 Other congenital deformities of hip Anteversion of femoral neck Congenital acetabular dysplasia Congenital coxa: valga vara
- Q65.9 Congenital deformity of hip, unspecified
Quality of Life in Males and Females With Idiopathic Scoliosis
Spine (Phila Pa 1976). 2019 Mar 15;44(6):404-410. doi: 10.1097/BRS.0000000000002857.
Diarbakerli E1,2, Grauers A1,3, Danielsson A4,5, Abbott A6, Gerdhem P1,2. Author information Abstract STUDY DESIGN: Cross-sectional. OBJECTIVE: To describe quality of life in males and females with idiopathic scoliosis. SUMMARY OF BACKGROUND DATA: Idiopathic scoliosis is a three-dimensional deformity affecting the growing spine. The prevalence of larger curves, requiring treatment, is higher in females. METHODS: This cross-sectional study comprised 1519 individuals with idiopathic scoliosis (211 males) with a mean (SD) age of 35.3 (14.9) years. They all answered the Scoliosis Research Society 22 revised (SRS-22r) questionnaire and EuroQol 5-dimension-index (EQ-5D). Five hundred twenty eight were surgically treated (78 males), 535 were brace treated (50 males), and 456 were untreated (83 males). The SRS-22r subscore (excluding the satisfaction domain), the SRS-22r domains and the EQ-5D index score were calculated. Subgroup analyses based on treatment and age were performed. Statistical comparisons were performed using analysis of covariance with adjustments for age and treatment. A P-value less than 0.05 was considered as statistical significant. RESULTS: The mean (SD) SRS-22r subscore was 4.19 (0.61) in males and 4.05 (0.61) in females (P = 0.010). The males had higher scores on the SRS-22r domains function (4.56 vs. 4.42), pain (4.20 vs. 4.00), and mental health (4.14 vs. 3.92) (all P < 0.05). The mean (SD) EQ-5D index score was 0.85 (0.22) for males and 0.81 (0.21) for females (P = 0.10). There were minor differences when comparing males and females in treatment and age groups, but both treated and untreated groups had reduced quality of life compared with the national norms. CONCLUSION: When compared with females, males with idiopathic scoliosis tend to have slightly higher scores in the scoliosis specific SRS-22r but not in the generic quality of life measurement EQ-5D. Quality of life is overall similar between males and females in treatment and age groups, but reduced in comparison with the general population. LEVEL OF EVIDENCE: 3. PMID: 30180148 DOI: 10.1097/BRS.0000000000002857
Quantitative Characteristics of Consecutive Lengthening Episodes in Early-onset Scoliosis (EOS) Patients With Dual Growth Rods
Spine (Phila Pa 1976). 2019 Mar 15;44(6):397-403. doi: 10.1097/BRS.0000000000002835.
Agarwal A1, Goswami A2, Vijayaraghavan GP2, Srivastava A2, Kandwal P3, Nagaraja UB4, Goel VK1, Agarwal AK1, Jayaswal A2. Author information Abstract STUDY DESIGN: A prospective single-center study. OBJECTIVE: The aim of this study was to record the characteristic forces and lengths observed during distraction episodes in early-onset scoliosis (EOS), and analyze their interdependencies on the key variability among the patients. SUMMARY OF BACKGROUND DATA: The goal of the growing-rod technique is to achieve deformity correction alongside maintaining growth of the spine. The deformity correction is achieved during the initial surgery, but follow-up distraction episodes are necessary to maintain the growth. The key variables, under the control of a surgeon, that affect the growth are the applied distraction forces and the distraction lengths. Since the advent of dual growth rod technique, there have been many studies exploring the relationship between these and the actual growth. However, there is sparse evidence on the actual magnitude of distraction forces, and none on its association with patient's parameters such as sex, age, and deformity. METHODS: In a consecutive series of 47 patients implanted with dual growth rods, the distraction forces (in N) and the lengths (in mm) achieved during each distraction episode and compared against the episode-specific demographics. The values obtained from each side, that is, concave and convex sides, were averaged to calculate the mean. Statistical analysis was performed using t-distribution because for each normalized time points (distraction episode). RESULTS: In cumulative, the distraction force increased by an amount of 268%, with 120% increase in the early stages (distractions episodes 1-6) and 68% increase in the later stages (distractions episodes 6-11), whereas the cumulative decrease in the length over 11 distractions episodes was 47%, with 34% and 20% in the early and later stages, respectively. The study does not identify any significant trend with respect to sex, age, and deformity. CONCLUSION: The distraction force and the length increased and decreased respectively with every consecutive distraction episode, with no correlation to sex, age, extent of deformity, or the extent of correction. LEVEL OF EVIDENCE: 5. PMID: 30095792 DOI: 10.1097/BRS.0000000000002835
Specific exercises reduce the need for bracing in adolescents with idiopathic scoliosis: A practical clinical trial
Ann Phys Rehabil Med. 2019 Mar;62(2):69-76. doi: 10.1016/j.rehab.2018.07.010. Epub 2018 Aug 24.
Negrini S1, Donzelli S2, Negrini A2, Parzini S2, Romano M2, Zaina F2. Author information Abstract BACKGROUND: In an ideal experimental setting, 2 randomized controlled trials recently showed the efficacy of physiotherapeutic scoliosis-specific exercises (PSSEs) for adolescents with idiopathic scoliosis (AIS). Now large observational studies are needed to check the generalizability of these results to everyday clinical life. OBJECTIVE: To explore the effectiveness of PSSEs for avoiding bracing or progression of AIS in everyday clinics. METHODS: This was a longitudinal comparative observational multicenter study, nested in a prospective database of outpatient tertiary referral clinics, including 327 consecutive patients. Inclusion criteria were AIS, age≥10 years old at first evaluation, Risser sign 0-2, and 11-20°Cobbangle. Exclusion criteria were consultations only and brace prescription at baseline. Groups performed PSSE according to the SEAS (Scientific Exercise Approach to Scoliosis) School, usual physiotherapy (UP) and no therapy (controls [CON]). End of treatment was medical discharge, Risser sign 3, or failure (defined by the need for bracing before the end of growth or Cobb angle>29°). The probability of failure was estimated by the risk ratio (RR) and 95% confidence interval (CI). The number needed to treat was estimated. Statistical analysis included intent-to-treat analysis, considering all participants (dropouts as failures), and efficacy analysis, considering only end-of-treatment participants. Propensity scores were used to reduce the potential effects of confounders related to the observational design. RESULTS: We included 293 eligible subjects after propensity score matching (SEAS, n=145; UP, n=95; controls, n=53). The risk of success was increased 1.7-fold (P=0.007) and 1.5-fold (P=0.006) with SEAS versus controls in the efficacy and intent-to-treat analyses, respectively, and the number needed to treat for testing SEAS versus controls was 3.5 (95% CI 3.2-3.7) and 1.8 (95% CI 1.5-2.0), respectively. The success rate was higher with SEAS than UP in the efficacy analysis. CONCLUSIONS: SEAS reduced the bracing rate in AIS and was more effective than UP. PSSEs are additional tools that can be included in the therapeutic toolbox for AIS treatment. Copyright © 2018 Elsevier Masson SAS. All rights reserved. KEYWORDS: Adolescents; Exercise; Scoliosis PMID: 30145241 DOI: 10.1016/j.rehab.2018.07.010
Mutations in INPP5K Cause a Form of Congenital Muscular Dystrophy Overlapping Marinesco-Sjögren Syndrome and Dystroglycanopathy
The incidence of common orthopaedic problems in newborn at Siriraj Hospital
J Med Assoc Thai. 2012 Sep;95 Suppl 9:S54-61.
Chotigavanichaya C, Leurmsumran P, Eamsobhana P, Sanpakit S, Kaewpornsawan K. Source Department of Orthopaedic Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. firstname.lastname@example.org
BACKGROUND: The congenital orthopaedic anomalies in Thai population had a limited data and the previously studies are based on only hospital chart records. OBJECTIVE: To determine the incidence of common congenital orthopedic problems by physical examination in newborn at Siriraj Hospital. MATERIAL AND METHOD: A prospective study was conducted by physical examination of 3,396 newborns from June 2009 to September 2009. All orthopaedic abnormalities of newborns were recorded along with maternal age, obstetric history of mother, complications during pregnancy, complications in labour stage, mode of delivery and presentation. Sex of newborn, birth weight, body length and APGAR score were recorded. RESULTS: Incidence of calcaneovalgus was found in 60:1,000 live births following by metatarsus adductus in 7.6:1,000, polydactyly or syndactyly in 2.6:1,000, talipes equninovarus in 2.4:1,000, brachial plexus injury in 1.5:1,000, developmental dysplasia of hip in 0.6:1,000, osteogenesis imperfecta in 0.6:1,000, skeketal dysplasia in 0.6:1,000, congenital vertical talus in 0.3: 1,000 and fracture clavicle at birth in 0.3: 1,000. CONCLUSION: In the present study, the calcaneovalgus was the most common orthopaedic problem followed by metatasus adductus, polydactyly or syndactyly.
Reproducibility of different screening classifications in ultrasonography of the newborn hip
BMC Pediatr. 2010 Dec 24;10:98. doi: 10.1186/1471-2431-10-98.
Peterlein CD, Schüttler KF, Lakemeier S, Timmesfeld N, Görg C, Fuchs-Winkelmann S, Schofer MD. Source Department of Orthopaedics and Rheumatology, University Hospital Giessen and Marburg, Marburg, Germany. email@example.com
BACKGROUND: Ultrasonography of the hip has gained wide acceptance as a primary method for diagnosis, screening and treatment monitoring of developmental hip dysplasia in infants. The aim of the study was to examine the degree of concordance of two objective classifications of hip morphology and subjective parameters by three investigators with different levels of experience. METHODS: In 207 consecutive newborns (101 boys; 106 girls) the following parameters were assessed: bony roof angle (α-angle) and cartilage roof angle (β-angle) according to Graf's basic standard method, "femoral head coverage" (FHC) as described by Terjesen, shape of the bony roof and position of the cartilaginous roof. Both hips were measured twice by each investigator with a 7.5 MHz linear transducer (SONOLINE G60S® ultrasound system, SIEMENS, Erlangen, Germany). RESULTS: Mean kappa-coefficients for the subjective parameters shape of the bony roof (0.97) and position of the cartilaginous roof (1.0) demonstrated high intra-observer reproducibility. Best results were achieved for α-angle, followed by β-angle and finally FHC. With respect to limits of agreement, inter-observer reproducibility was calculated less precisely. CONCLUSIONS: Higher measurement differences were evaluated more in objective scorings. Those variations were observed by every investigator irrespective of level of experience.
Clinical examination versus ultrasonography in detecting developmental dysplasia of the hip
Int Orthop. 2008 Jun;32(3):415-9. Epub 2007 Mar 1.
Dogruel H, Atalar H, Yavuz OY, Sayli U. Source Department of Orthopaedic Surgery, Güven Hospital, Ankara, Turkey. firstname.lastname@example.org Abstract Although hip ultrasonography is gaining acceptance as the most effective method for the early diagnosis of developmental dysplasia of the hip, there is still some controversy regarding the use of ultrasonography as a screening method. The purpose of this study was to investigate prospectively the capacity of clinical examination findings and associated risk factors to detect developmental dysplasia of the hip defined ultrasonographically in infants. A total of 3,541 infants underwent clinical examination and hip ultrasonography. Measured against ultrasonography as a standard, the sensitivity and specificity of clinical examination were 97% and 13.68%, respectively. Graf type IIb or more severe developmental dysplasia was found in 167 infants (208 hips), at an overall frequency of 4.71%. Graf type IIa physiological immaturity was encountered in 838 hips, and of these, 15 hips (1.78%) developed Graf type IIb dysplasia and underwent treatment. Patient characteristics that were found to be significant risk factors were swaddling use, female gender, breech delivery and positive family history. Given its low specificity, our findings suggest that clinical examination does not reliably detect ultrasonographically defined developmental dysplasia of the hip in infants being screened for this disease. Comment in Comment on: Clinical examination versus ultrasonography in detecting developmental dysplasia of the hip. [Int Orthop. 2009]
The structure of the N-terminal actin-binding domain of human dystrophin and how mutations in this domain may cause Duchenne or Becker muscular dystrophy
Structure. 2000 May 15;8(5):481-91.
Norwood FL, Sutherland-Smith AJ, Keep NH, Kendrick-Jones J.
SourceStructural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, CB2 2QH, UK.
BACKGROUND:Dystrophin is an essential component of skeletal muscle cells. Its N-terminal domain binds to F-actin and its C terminus binds to the dystrophin-associated glycoprotein (DAG) complex in the membrane. Dystrophin is therefore thought to serve as a link from the actin-based cytoskeleton of the muscle cell through the plasma membrane to the extracellular matrix. Pathogenic mutations in dystrophin result in Duchenne or Becker muscular dystrophy.RESULTS:The crystal structure of the dystrophin actin-binding domain (ABD) has been determined at 2.6 A resolution. The structure is an antiparallel dimer of two ABDs each comprising two calponin homology domains (CH1 and CH2) that are linked by a central alpha helix. The CH domains are both alpha-helical globular folds. Comparisons with the structures of utrophin and fimbrin ABDs reveal that the conformations of the individual CH domains are very similar to those of dystrophin but that the arrangement of the two CH domains within the ABD is altered. The dystrophin dimer reveals a change of 72 degrees in the orientation of one pair of CH1 and CH2 domains (from different monomers) relative to the other pair when compared with the utrophin dimer. The dystrophin monomer is more elongated than the fimbrin ABD.CONCLUSIONS:The dystrophin ABD structure reveals a previously uncharacterised arrangement of the CH domains within the ABD. This observation has implications for the mechanism of actin binding by dystrophin and related proteins. Examining the position of three pathogenic missense mutations within the structure suggests that they exert their effects through misfolding of the ABD, rather than through disruption of the binding to F-actin.
Developmental Dysplasia of the Hip
The effect of functional splinting on mild dysplastic hips after walking onset
BMC Pediatr. 2005 Jun 15;5(1):17.
CONCLUSION: Considering the characteristics of this study, there seems to be no strong rationale supporting the use of an abduction device in growing children. As no significant difference between treatment groups is apparent, a future controlled prospective study on splinting effects can be considered ethically allowed.
Implementation by simulation; strategies for ultrasound screening for hip dysplasia in the Netherlands
Assessing subgroup effects with binary data: can the use of different effect measures lead to different conclusions?
Congenital scoliosis in monozygotic twins: case report and review of possible factors contributing to its development
Developmental dysplasia of the hip References
1: Sewell MD, Rosendahl K, Eastwood DM. Developmental dysplasia of the hip. BMJ. 2009 Nov 24;339:b4454. doi: 10.1136/bmj.b4454. Review. PubMed PMID: 19934187.
2: Hurley A. DDH: causes and examination. Community Pract. 2009 Sep;82(9):36-7. Review. PubMed PMID: 19788124.
3: Karmazyn BK, Gunderman RB, Coley BD, Blatt ER, Bulas D, Fordham L, Podberesky DJ, Prince JS, Paidas C, Rodriguez W; American College of Radiology. ACR Appropriateness Criteria on developmental dysplasia of the hip--child. J Am Coll Radiol. 2009 Aug;6(8):551-7. PubMed PMID: 19643382.
4: van der Sluijs JA, De Gier L, Verbeke JI, Witbreuk MM, Pruys JE, van Royen BJ. Prolonged treatment with the Pavlik harness in infants with developmental dysplasia of the hip. J Bone Joint Surg Br. 2009 Aug;91(8):1090-3. PubMed
5: Dwek JR. The hip: MR imaging of uniquely pediatric disorders. Magn Reson Imaging Clin N Am. 2009 Aug;17(3):509-20, vi. Review. PubMed PMID: 19524199.
6: Vukasinoviƒá Z, Zivkoviƒá Z, Vucetiƒá C. [Developmental hip dysplasia in adolescence]. Srp Arh Celok Lek. 2009 Jul-Aug;137(7-8):440-3. Review. Serbian. PubMed PMID 19764602
7: Venc√°lkov√° S, Janata J. [Evaluation of screening for developmental dysplasia of the hip in the Liberec region in 1984-2005]. Acta Chir Orthop Traumatol Cech. 2009 Jun;76(3):218-24. Czech. PubMed PMID 19595284
8: Ohmori T, Endo H, Mitani S, Minagawa H, Tetsunaga T, Ozaki T. Radiographic prediction of the results of long-term treatment with the Pavlik harness for developmental dislocation of the hip. Acta Med Okayama. 2009 Jun;63(3):123-8. PubMed PMID: 19571898.
9: Paton RW, Choudry Q. Neonatal foot deformities and their relationship to developmental dysplasia of the hip: an 11-year prospective, longitudinal observational study. J Bone Joint Surg Br. 2009 May;91(5):655-8. PubMed PMID: 19407302.
10: Roposch A, St√∂hr KK, Dobson M. The effect of the femoral head ossific nucleus in the treatment of developmental dysplasia of the hip. A meta-analysis. J Bone Joint Surg Am. 2009 Apr;91(4):911-8. PubMed PMID: 19339576.
11: Vandevenne JE, Lincoln T, Butts Pauly K, Rinsky L, Lang PK. Magnetic resonance imaging-guided closed reduction treatment for developmental dysplasia of the hip. Singapore Med J. 2009 Apr;50(4):407-11. PubMed PMID: 19421687.
12: Shipman SA. Risk management and developmental dysplasia of the hip: primum non nocere. Pediatrics. 2009 Mar;123(3):e546; author reply e546-7. PubMed PMID: 19254992.
13: Ranawat V, Rosendahl K, Jones D. MRI after operative reduction with femoral osteotomy in developmental dysplasia of the hip. Pediatr Radiol. 2009 Feb;39(2):161-3. Epub 2008 Dec 4. PubMed PMID: 19052737.
14: Paton RW. Developmental dysplasia of the hip: ultrasound screening and treatment. How are they related? Hip Int. 2009 Jan-Mar;19 Suppl 6:S3-8. PubMed PMID: 19306241.
15: Harris WH. The correlation between minor or unrecognized developmental deformities and the development of osteoarthritis of the hip. Instr Course Lect. 2009;58:257-9. PubMed PMID: 19385539.
16: Li J, Xu W, Xu L, Liang Z. Hip resurfacing for the treatment of developmental dysplasia of the hip. Orthopedics. 2008 Dec;31(12). pii: orthosupersite.com/view.asp?rID=32924. PubMed PMID: 19226067.
17: Carmichael KD, Longo A, Yngve D, Hernandez JA, Swischuk L. The use of ultrasound to determine timing of Pavlik harness discontinuation in treatment of developmental dysplasia of the hip. Orthopedics. 2008 Oct;31(10). pii: orthosupersite.com/view.asp?rID=31512. PubMed PMID: 19226016.
18: Green K, Oddie S. The value of the postnatal examination in improving child health. Arch Dis Child Fetal Neonatal Ed. 2008 Sep;93(5):F389-93. Epub 2008 May 7. Review. PubMed PMID: 18463120.
19: Gelfer P, Kennedy KA. Developmental dysplasia of the hip. J Pediatr Health Care. 2008 Sep-Oct;22(5):318-22. Review. PubMed PMID: 18761234.
20: L√≥pez-Carre√±o E, Carillo H, Guti√©rrez M. Dega versus Salter osteotomy for the treatment of developmental dysplasia of the hip. J Pediatr Orthop B. 2008 Sep;17(5):213-21. PubMed PMID: 19471172.
21: Zhang H. [The problems and strategies in the diagnosis and treatment of developmental dysplasia of hip]. Zhonghua Wai Ke Za Zhi. 2008 Sep 1;46(17):1284-7. Chinese. PubMed PMID: 19094554.
22: Li ZR. [Developmental dislocation or dysplasia of hip: diagnosing early and performing the operation correctly according to the classification]. Zhonghua Wai Ke Za Zhi. 2008 Sep 1;46(17):1281-3. Chinese. PubMed PMID: 19094553.
23: Pach M, Kam√≠nek P, Mikul√≠k J. [Wagner stockings for the treatment of developmental dysplasia of the hip diagnosed early by general screening]. Acta Chir Orthop Traumatol Cech. 2008 Aug;75(4):277-81. Czech. PubMed PMID: 18760083.
24: Ceylaner G, Ceylaner S, Ust√ºnkan F, Inan M. [Autosomal dominant inheritance of congenital dislocation of the hip in 16 members of a family]. Acta Orthop Traumatol Turc. 2008 Aug-Oct;42(4):289-91. Turkish. PubMed PMID: 19060525.
25: Finne PH, Dalen I, Ikonomou N, Ulimoen G, Hansen TW. Diagnosis of congenital hip dysplasia in the newborn. Acta Orthop. 2008 Jun;79(3):313-20. PubMed PMID: 18622833.
26: Hvid I. Neonatal hip instability, developmental dysplasia of the acetabulum, and the risk of early osteoarthrosis. Acta Orthop. 2008 Jun;79(3):311-2. PubMed PMID: 18622832.
27: Dogruel H, Atalar H, Yavuz OY, Sayli U. Clinical examination versus ultrasonography in detecting developmental dysplasia of the hip. Int Orthop. 2008 Jun;32(3):415-9. Epub 2007 Mar 1. PubMed PMID: 17333184; PubMed Central PMCID: PMC2323411.
28: Henle P, Tannast M, Siebenrock KA. [Imaging in developmental dysplasia of the hip]. Orthopade. 2008 Jun;37(6):525-31. German. PubMed PMID: 18496670.
29: Nelitz M, Reichel H. [Nonsurgical treatment of developmental dysplasia of the hip]. Orthopade. 2008 Jun;37(6):550, 552-5. German. PubMed PMID: 18493741.
30: G√ºnther KP. [Hip dysplasia--update 2008]. Orthopade. 2008 Jun;37(6):513-4. German. PubMed PMID: 18491074.
31: Ziegler J, Thielemann F, Mayer-Athenstaedt C, G√ºnther KP. [The natural history of developmental dysplasia of the hip. A meta-analysis of the published literature]. Orthopade. 2008 Jun;37(6):515-6, 518-24. German. PubMed PMID: 18483804.
32: Kotnis R, Spiteri V, Little C, Theologis T, Wainwright A, Benson MK. Hip arthrography in the assessment of children with developmental dysplasia of the hip and Perthes' disease. J Pediatr Orthop B. 2008 May;17(3):114-9. PubMed PMID: 18391807.
33: Kohler R, Seringe R. [Congenital dislocation of the hip: current concepts as a preliminary for diagnosis and treatment]. Rev Chir Orthop Reparatrice Appar Mot. 2008 May;94(3):217-27. Epub 2008 Mar 11. Review. French. PubMed PMID: 18456056.
34: Inan M, Korkusuz F. Developmental dysplasia of the hip : editorial comment. Clin Orthop Relat Res. 2008 Apr;466(4):761-2. Epub 2008 Mar 12. PubMed PMID: 18335296; PubMed Central PMCID: PMC2504645.
35: Peled E, Eidelman M, Katzman A, Bialik V. Neonatal incidence of hip dysplasia: ten years of experience. Clin Orthop Relat Res. 2008 Apr;466(4):771-5. Epub 2008 Feb 21. PubMed PMID: 18288551; PubMed Central PMCID: PMC2504674.
36: Grissom L, Harcke HT, Thacker M. Imaging in the surgical management of developmental dislocation of the hip. Clin Orthop Relat Res. 2008 Apr;466(4):791-801. Epub 2008 Feb 21. Review. PubMed PMID: 18288547; PubMed Central PMCID: PMC2504666.
37: Kapicioglu MI, Korkusuz F. Diagnosis of developmental dislocation of the hip by sonospectrography. Clin Orthop Relat Res. 2008 Apr;466(4):802-8. Epub 2008 Feb 15. PubMed PMID: 18274713; PubMed Central PMCID: PMC2504664.
38: Luther AZ, Clarke NM. Developmental dysplasia of the hip and occult neurologic disorders. Clin Orthop Relat Res. 2008 Apr;466(4):871-7. Epub 2008 Jan 30. PubMed PMID: 18231844; PubMed Central PMCID: PMC2504646.
39: Strandberg C, Konradsen LA, Ellitsgaard N, Glassau EN. [Ultrasound in the diagnosis and treatment of developmental dysplasia of the hip. Evaluation of a selective screening procedure]. Ugeskr Laeger. 2008 Jan 21;170(4):235-40. Danish. PubMed PMID: 18282454.
40: Dai J, Shi D, Zhu P, Qin J, Ni H, Xu Y, Yao C, Zhu L, Zhu H, Zhao B, Wei J, Liu B, Ikegawa S, Jiang Q, Ding Y. Association of a single nucleotide polymorphism in growth differentiate factor 5 with congenital dysplasia of the hip: a case-control study. Arthritis Res Ther. 2008;10(5):R126. Epub 2008 Oct 24. PubMed PMID: 18947434; PubMed Central PMCID: PMC2592816.
41: Inan M, Chan G, Bowen JR. The correction of leg-length discrepancy after treatment in developmental dysplasia of the hip by using a percutaneous epiphysiodesis. J Pediatr Orthop B. 2008 Jan;17(1):43-6. PubMed PMID: 18043377.
42: Treiber M, Tomazic T, Tekauc-Golob A, Zolger J, Korpar B, Burja S, Takac I, Sikosek A. Ultrasound screening for developmental dysplasia of the hip in the newborn: a population-based study in the Maribor region, 1997-2005. Wien Klin Wochenschr. 2008;120(1-2):31-6. PubMed PMID: 18239989.
43: Schwend RM, Schoenecker P, Richards BS, Flynn JM, Vitale M; Pediatric Orthopaedic Society of North America. Screening the newborn for developmental dysplasia of the hip: now what do we do? J Pediatr Orthop. 2007 Sep;27(6):607-10. PubMed PMID: 17717457.
44: Uzel M, Ergun GU, Ekerbicer HC. The knowledge and attitudes of the primary care physicians on developmental dysplasia of the hip. Saudi Med J. 2007 Sep;28(9):1430-4. PubMed PMID: 17768475.
45: Ergun UG, Uzel M, Celik M, Ekerbicer H. The knowledge, attitude and practice of the primary and secondary care nurse-midwife practitioners on developmental dysplasia of hip. Nurse Educ Today. 2007 Aug;27(6):635-42. Epub 2006 Nov 22. PubMed PMID: 17123669.
46: Mitchell PD, Chew NS, Goutos I, Healy JC, Lee JC, Evans S, Hulme A. The value of MRI undertaken immediately after reduction of the hip as a predictor of long-term acetabular dysplasia. J Bone Joint Surg Br. 2007 Jul;89(7):948-52. PubMed PMID: 17673592.
47: Papadimitriou NG, Papadimitriou A, Christophorides JE, Beslikas TA, Panagopoulos PK. Late-presenting developmental dysplasia of the hip treated with the modified Hoffmann-Daimler functional method. J Bone Joint Surg Am. 2007 Jun;89(6):1258-68. PubMed PMID: 17545429.
48: Bancroft LW, Merinbaum DJ, Zaleski CG, Peterson JJ, Kransdorf MJ, Berquist TH. Hip ultrasound. Semin Musculoskelet Radiol. 2007 Jun;11(2):126-36. Review. PubMed PMID: 18095245.
49: Dezateux C, Rosendahl K. Developmental dysplasia of the hip. Lancet. 2007 May 5;369(9572):1541-52. Review. PubMed PMID: 17482986.
50: Campos-Outcalt D. Screening for dysplasia of the hip: weigh harms and benefits. Am Fam Physician. 2007 May 1;75(9):1304. PubMed PMID: 17508522.
51: Jellicoe P, Aitken A, Wright K. Ultrasound screening in developmental hip dysplasia: do all scanned hips need to be followed up? J Pediatr Orthop B. 2007 May;16(3):192-5. PubMed PMID: 17414780.
52: Kamath S, Mehdi A, Wilson N, Duncan R. The lack of evidence of the effect of selective ultrasound screening on the incidence of late developmental dysplasia of the hip in the Greater Glasgow Region. J Pediatr Orthop B. 2007 May;16(3):189-91. PubMed PMID: 17414779.
53: Hobbs DL, Mickelsen W, Johnson C. Developmental dysplasia of the hip. Radiol Technol. 2007 May-Jun;78(5):423-8. Review. PubMed PMID: 17519380.
54: McCarthy JJ, MacEwen GD. Hip arthroscopy for the treatment of children with hip dysplasia: a preliminary report. Orthopedics. 2007 Apr;30(4):262-4. PubMed PMID: 17424686.
55: Lef√®vre Y, Laville JM, Salmeron F. [Early short-term treatment of neonatal hip instability with the Pavlik harness]. Rev Chir Orthop Reparatrice Appar Mot. 2007 Apr;93(2):150-6. French. PubMed PMID: 17401288.
56: Glastrup H. [Hip dysplasia: clinical assessment, radiologic evaluation and reference]. Ugeskr Laeger. 2007 Mar 12;169(11):1030. Danish. PubMed PMID: 17378027.
57: Pashapour N, Golmahammadlou S. Study on the diagnosis time of developmental dysplasia of the hip. East Mediterr Health J. 2007 Mar-Apr;13(2):465-9. PubMed PMID: 17684868.
58: Schoenecker PL, Flynn JM. Screening for developmental dysplasia of the hip. Pediatrics. 2007 Mar;119(3):652-3; author reply 653-4. PubMed PMID: 17332226.
59: Rafique A, Set P, Berman L. Late presentation of developmental dysplasia of the hip following normal ultrasound examination. Clin Radiol. 2007 Feb;62(2):181-4. PubMed PMID: 17207703.
60: Nakamura J, Kamegaya M, Saisu T, Someya M, Koizumi W, Moriya H. Treatment for developmental dysplasia of the hip using the Pavlik harness: long-term results. J Bone Joint Surg Br. 2007 Feb;89(2):230-5. Erratum in: J Bone Joint Surg Br. 2007 May;89(5):707. PubMed PMID: 17322441.
61: Roposch A, Wright JG. Increased diagnostic information and understanding disease: uncertainty in the diagnosis of developmental hip dysplasia. Radiology. 2007 Feb;242(2):355-9. PubMed PMID: 17255407.
62: Troelsen A, R√∏mer L, S√∏balle K. [Hip dysplasia: clinical assessment, radiologic evaluation and reference]. Ugeskr Laeger. 2007 Jan 29;169(5):394-6. Danish. PubMed PMID: 17280629.
63: Inan M. [Current approaches to the treatment of developmental dysplasia of the hip]. Acta Orthop Traumatol Turc. 2007;41 Suppl 1:68-73. Review. Turkish. PubMed PMID: 17483626.
64: T√ºmer Y, Aƒüu≈ü H, Bi√ßimoƒülu A. [When should secondary procedures be performed in residual hip dysplasia?]. Acta Orthop Traumatol Turc. 2007;41 Suppl 1:60-7. Review. Turkish. PubMed PMID: 17483625.
65: Aksoy MC. [Closed reduction in the treatment of developmental dysplasia of the hip]. Acta Orthop Traumatol Turc. 2007;41 Suppl 1:25-30. Review. Turkish. PubMed PMID: 17483620.
66: Graf R. [The use of ultrasonography in developmental dysplasia of the hip]. Acta Orthop Traumatol Turc. 2007;41 Suppl 1:6-13. Review. Turkish. PubMed PMID: 17483617.
67: Todorov S, Asparukhov A, Velkova A. [Early diagnosis of hip joint dysplasia in neonatal age--clinical or ultrasound methods]. Akush Ginekol (Sofiia). 2007;46 Suppl 1:46-9. Bulgarian. PubMed PMID: 18173013.
68: Kokavec M, Bialik V. Developmental dysplasia of the hip. Prevention and real incidence. Bratisl Lek Listy. 2007;108(6):251-4. PubMed PMID: 17972535.
69: Lipton GE, Guille JT, Altiok H, Bowen JR, Harcke HT. A reappraisal of the Ortolani examination in children with developmental dysplasia of the hip. J Pediatr Orthop. 2007 Jan-Feb;27(1):27-31. PubMed PMID: 17195793.
70: Desprechins B, Ernst C, de Mey J. Screening for developmental dysplasia of the hip. JBR-BTR. 2007 Jan-Feb;90(1):4-5. PubMed PMID: 17405613.
71: Storer SK, Skaggs DL. Developmental dysplasia of the hip. Am Fam Physician. 2006 Oct 15;74(8):1310-6. Review. PubMed PMID: 17087424.
72: Yawn BP, Mabry IR, Ko S. Ultrasonography in the assessment of developmental dysplasia of the hip. Am Fam Physician. 2006 Oct 15;74(8):1284-5. PubMed PMID: 17087422.
73: Pap K, Kiss S, Shisha T, Marton-Sz√ºcs G, Sz√∂ke G. The incidence of avascular necrosis of the healthy, contralateral femoral head at the end of the use of Pavlik harness in unilateral hip dysplasia. Int Orthop. 2006 Oct;30(5):348-51. Epub 2006 Apr 26. Erratum in: Int Orthop. 2006 Oct;30(5):352. PubMed PMID: 16639593.
74: Mabry IR, Luckhaupt S. Screening for developmental dysplasia of the hip. (Quiz 1005-6). Am Fam Physician. 2006 Sep 15;74(6):1005-6. PubMed PMID: 17002037.
75: Arumilli BR, Koneru P, Garg NK, Davies R, Saville S, Sampath J, Bruce C. Is secondary radiological follow-up of infants with a family history of developmental dysplasia of the hip necessary? J Bone Joint Surg Br. 2006 Sep;88(9):1224-7. PubMed PMID: 16943477.
76: Spyropoulou AC, Zervas IM, Soldatos CR. Hip dysplasia following a case of olanzapine exposed pregnancy: a questionable association. Arch Womens Ment Health. 2006 Jul;9(4):219-22. Epub 2006 Jun 8. PubMed PMID: 16755330.
77: Uras I, Yavuz OY, Kose KC, Atalar H, Uras N, Karadag A. Radiographic artifact mimicking epiphysis of the femoral head in a seven-month-old girl. J Natl Med Assoc. 2006 Jul;98(7):1181-2. PubMed PMID: 16895292; PubMed Central PMCID: PMC2569463.
78: Ghanem I, M√©garban√© A. Aplasia of the pubic bone in conjunction with hip dislocation. J Pediatr Orthop B. 2006 Jul;15(4):309; author reply 309-10. PubMed PMID: 16751746.
79: Carney BT, Vanek EA. Incidence of hip dysplasia in idiopathic clubfoot. J Surg Orthop Adv. 2006 Summer;15(2):71-3. PubMed PMID: 16919196.
80: U.S. Preventive Service Task Force. Screening for developmental dysplasia of the hip: recommendation statement. Am Fam Physician. 2006 Jun 1;73(11):1992-6. Review. PubMed PMID: 16770931.
81: Moulies D, Peyrou P. [Failure in the screening and diagnosis of developmental dysplasia of the hip]. Arch Pediatr. 2006 Jun;13(6):696-9. Epub 2006 May 11. French. PubMed PMID: 16697596.
82: Fenoll B. [Guidelines for improving the screening of developmental dysplasia of the hip]. Arch Pediatr. 2006 Jun;13(6):699-702. Epub 2006 May 11. French. PubMed PMID: 16697568.
83: Kohler R, Dohin B. [Screening of congenital dislocation of the hip in the newborn]. Arch Pediatr. 2006 Jun;13(6):685-8. Epub 2006 May 11. French. PubMed PMID: 16697156.
84: Lauge-Pedersen H, Gustafsson J, H√§gglund G. 6 Weeks with the von Rosen splint is sufficient for treatment of neonatal hip instability. Acta Orthop. 2006 Apr;77(2):257-61. PubMed PMID: 16752287.
85: Forlin E, Munhoz da Cunha LA, Figueiredo DC. Treatment of developmental dysplasia of the hip after walking age with open reduction, femoral shortening, and acetabular osteotomy. Orthop Clin North Am. 2006 Apr;37(2):149-60, vi. Review. PubMed PMID: 16638446.
86: Synder M, Harcke HT, Domzalski M. Role of ultrasound in the diagnosis and management of developmental dysplasia of the hip: an international perspective. Orthop Clin North Am. 2006 Apr;37(2):141-7, v. Review. PubMed PMID: 16638445.
87: Hart ES, Albright MB, Rebello GN, Grottkau BE. Developmental dysplasia of the hip: nursing implications and anticipatory guidance for parents. Orthop Nurs. 2006 Mar-Apr;25(2):100-9; quiz 110-1. Review. PubMed PMID: 16572026.
88: US Preventive Services Task Force. Screening for developmental dysplasia of the hip: recommendation statement. Pediatrics. 2006 Mar;117(3):898-902. PubMed PMID: 16510673.
89: Vukasinoviƒá Z, Vucetiƒá C, Cobeljiƒá G, Bascareviƒá Z, Slavkoviƒá N. [Developmental dislocation of the hip is still important problem--therapeutic guidelines]. Acta Chir Iugosl. 2006;53(4):17-9. Review. Serbian. PubMed PMID: 17688027.
90: Sibi≈Ñiski M, Grzegorzewski A, Synder M. [Hip joint development after treatment the developmental dislocation with overhead traction]. Chir Narzadow Ruchu Ortop Pol. 2006;71(2):127-31. Polish. PubMed PMID: 17133836.
91: Dzhalilov AP. [The significance of ultrasonic investigation of the hip joint with dysplasia and congenital hip joint dislocation]. Vestn Khir Im I I Grek. 2006;165(2):67-70. Russian. PubMed PMID: 16752643.
92: Kowalczyk B, Felus J, Kwinta P. [Developmental dysplasia of the hip: the problems in the diagnosis process in our own experience]. Med Wieku Rozwoj. 2005 Jul-Sep;9(3 Pt 1):395-406. Polish. PubMed PMID: 16547386.
93: Schirrer J, de Billy B, de Billy M. [Tracking dysplasia and congenital luxation of the hip]. Arch Pediatr. 2005 Jun;12(6):789-91. Review. French. PubMed PMID: 15904806.
94: O'Riordan C, Condon F, Conhyea D, Kaliszer M, O'Brien T. The role of ultrasound screening for hip dysplasia. Ir Med J. 2005 May;98(5):147-9. PubMed PMID: 16010785.
95: Danielsson L, Hansson G, Landin L. Good results after treatment with the Frejka pillow for hip dysplasia in newborn infants: a 3-year to 6-year follow-up study. J Pediatr Orthop B. 2005 May;14(3):228-30; author reply 230-1. PubMed PMID: 15812298.
96: Elbourne D, Dezateux C. Hip dysplasia and ultrasound imaging of whole populations: the precautionary principle revisited. Arch Dis Child Fetal Neonatal Ed. 2005 Jan;90(1):F2-3. PubMed PMID: 15613566; PubMed Central PMCID: PMC1721803.
97: Felu≈õ J, Kowalczyk B. [Clinicaly silent developmental hip dysplasia--significancy of the hip ultrasonographic examination]. Chir Narzadow Ruchu Ortop Pol. 2005;70(6):397-400. Polish. PubMed PMID: 16875179.
98: Weinstein SL, Mubarak SJ, Wenger DR. Developmental hip dysplasia and dislocation: Part I. Instr Course Lect. 2004;53:523-30. Review. PubMed PMID: 15116641.
99: Paton RW, Paniker J. The efficacy of the Pavlik harness, the Craig splint and the von Rosen splint in the management of neonatal dysplasia of the hip. J Bone Joint Surg Br. 2003 Sep;85(7):1086; author reply 1086. PubMed PMID: 14516054.
100: Avci S. The efficacy of the Pavlik harness, the Craig splint and the von Rosen splint in the management of neonatal dysplasia of the hip. J Bone Joint Surg Br. 2003 Sep;85(7):1085-6; author reply 1086. PubMed PMID: 14516053.
101: Kalifa G. [Screening for developmental dysplasia of the hip]. J Radiol. 2003 Apr;84(4 Pt 1):354. French. PubMed PMID: 12759648.
102: Mostert AK, Tulp NJ, Castelein RM, Inoue T, Naito M, Nomiyama H. Treatment of developmental dysplasia of the hip with the Pavlik Harness: factors for predicting unsuccessful reduction. J Pediatr Orthop B. 2002 Apr;11(2):181. PubMed PMID: 11943996.
103: Willis RB. Developmental dysplasia of the hip: assessment and treatment before walking age. Instr Course Lect. 2001;50:541-5. Review. PubMed PMID: 11372357.
104: Bauchner H. Developmental dysplasia of the hip (DDH): an evolving science. Arch Dis Child. 2000 Sep;83(3):202. Review. PubMed PMID: 10952632; PubMed Central PMCID: PMC1718448.
105: Chell J, Hunter JB. At the crossroads--neonatal detection of developmental dysplasia of the hip. J Bone Joint Surg Br. 2000 Sep;82(7):1083. PubMed PMID: 11041606.
106: Hennrikus WL. Developmental dysplasia of the hip: diagnosis and treatment in children younger than 6 months. Pediatr Ann. 1999 Dec;28(12):740-6. Review. PubMed PMID: 10615675.
107: Patel H. Hip dysplasia in infants. Pediatrics. 1999 Dec;104(6):1418. PubMed PMID: 10610501.
108: Ant√≥n Rodrig√°lvarez LM. [Developmental dysplasia of the hip]. An Esp Pediatr. 1998 Oct;49(4):337-8. Spanish. PubMed PMID: 9859544.
109: Fern√°ndez-Viadero C, Pe√±a Sarabia N, Verduga V√©lez R, Crespo Santiago D. Are congenital malformations in older people underdiagnosed? J Am Geriatr Soc. 1997 Jul;45(7):895-7. PubMed PMID: 9215352.
110: Graf R. [Developmental hip disorders in infants. Diagnosis and therapy]. Orthopade. 1997 Jan;26(1):1. German. PubMed PMID: 9082297.
111: Matthiessen HD. [Forensic problems in the treatment of hip dysplasias and dislocations]. Z Orthop Ihre Grenzgeb. 1996 Nov-Dec;134(6):Oa10-2. German. PubMed PMID: 9027112.
112: Jonides L, Rudy C, Walsh S. Developmental dysplasia of the hip: what's new in the 1990's? J Pediatr Health Care. 1996 Mar-Apr;10(2):85; quiz 95-6. PubMed PMID: 8847610.
113: Anticeviƒá D. [Congenital hip dislocation or developmental hip displacement?]. Lijec Vjesn. 1995 May-Jun;117(5-6):150-1. Croatian. PubMed PMID: 8600329.
114: Morcuende JA, Weinstein SL. New developments in developmental dysplasia of the hip. Curr Probl Pediatr. 1994 Nov-Dec;24(10):335-43. Review. PubMed PMID: 7867374.
115: Khouri N, Chaumien JP. [Congenital hip dislocation. Physiopathology]. Soins Gynecol Obstet Pueric Pediatr. 1994 Jun-Jul;(157-158):3-7. French. PubMed PMID: 8091282.
116: de Courtivron B, Chaumet P, Duclos M, Le Bec A, Kerdraon C. [Congenital hip dislocation. Reception at hospitalization]. Soins Gynecol Obstet Pueric Pediatr. 1994 Jun-Jul;(157-158):28-34. French. PubMed PMID: 8091281.
117: Pizzutillo PD. Developmental dysplasia of the hip. Instr Course Lect. 1994;43:179-83. Review. PubMed PMID: 9097147.
118: Jones DA, Beynon D, Littlepage BN. Audit of an official recommendation on screening for congenital dislocation of the hip. BMJ. 1991 Jun 15;302(6790):1435-6. PubMed PMID: 2070110; PubMed Central PMCID: PMC1670144.
119: McDermott V. Screening for congenital hip dysplasia. Lancet. 1991 Jun 8;337(8754):1421. PubMed PMID: 1674803.
120: Dost√°l M. [Congenital hip dysplasia, possibilities of diagnosis and treatment]. Cesk Pediatr. 1984 Aug;39(8):448-50. Czech. PubMed PMID: 6499054.
121: Puzyna W. [Congenital dysplasia of the hip joint]. Pieleg Polozna. 1984;(6):8, 12. Polish. PubMed PMID: 6567211.
122: Emr J. [Factors related to congenital hip dysplasia analyzed from the visual aspect of the body asymmetry syndrome]. Acta Chir Orthop Traumatol Cech. 1983 Aug;50(4):311-7. Czech. PubMed PMID: 6650056.
123: Fixsen J. Congenital dislocation of the hip and club foot in the young child. Health Visit. 1983 Aug;56(8):281-3. PubMed PMID: 6555169.
124: Mollan RA. Congenital dislocation of the hip. Br Med J (Clin Res Ed). 1983 Jan 29;286(6362):396. PubMed PMID: 6402120; PubMed Central PMCID: PMC1546940.
125: Seringe R. [Detection and management of congenital dysplasia and dislocation of the hip in neonates and infants]. Ann Pediatr (Paris). 1982 Sep;29(7):499-508. French. PubMed PMID: 7181388.
126: Alkalay I, Shezar Y, Grumberg B, Shmuel Y. [Congenital dislocation of the hip joint in Western Galilee]. Harefuah. 1982 Jul;103(1-2):6-8. Hebrew. PubMed PMID: 7160754.
127: Hirsch PJ, Hirsch SA, Reedman L, Weiss AB, Rineberg BA. Treatment of hip dysplasia in the first nine months. Orthop Clin North Am. 1982 Jul;13(3):605-18. PubMed PMID: 7099590.
128: Kulin NG. [Organization of the early detection and treatment of coxofemoral joint dysplasia and congenital hip dislocation]. Med Sestra. 1981 Sep;40(9):23-5. Russian. PubMed PMID: 6913764.
129: Seifert I. [Manual therapeutic aspects of hip dysplasia - study with newborns]. Beitr Orthop Traumatol. 1981 Mar;28(3):161-4. German. PubMed PMID: 7236190.
130: Dai XQ. [Early treatment of congenital dislocation of hip with "clothing-harness" (author's transl)]. Zhonghua Wai Ke Za Zhi. 1981 Feb;19(2):104-6. Chinese. PubMed PMID: 7261744.
131: Vizkelety T. [Current problems of congenital hip dislocation and dysplasia]. Chir Narzadow Ruchu Ortop Pol. 1981;46(5):429-34. Polish. PubMed PMID: 7333134.
132: Mezhenina EP, Kutsenok IaB. [Organization of the prevention, early detection and treatment of congenital hip joint dysplasia]. Ortop Travmatol Protez. 1980 Jun;(6):67-71. Russian. PubMed PMID: 7402622.
133: Dunn DM, O'Riordan SM. Dislocated and dislocatable hip in the newborn. Br Med J. 1980 Feb 16;280(6212):481. PubMed PMID: 7370541; PubMed Central PMCID: PMC1600465.
134: Gaubert J, Bardier M, Bousigue JY, Marty M. [Epiphyseal dislocation in the new born]. Ann Pediatr (Paris). 1979 Mar;26(3):149-53. Review. French. PubMed PMID: 16108275.
135: Munzinger U, Meyer RP, Gschwend N. [Conservative management of congenital hip dislocation. c) functioning after early therapy of hip dysplasia and hip dislocation]. Orthopade. 1979 Jan;8(1):22-9. German. PubMed PMID: 15655953.
136: Dimon JH 3rd. Observation of the gluteal fold in hip dysplasia. Clin Orthop Relat Res. 1974;(103):19. PubMed PMID: 4414870.
137: Tr√§ger G, Blankenburg H. [Results of conservative therapy of so-called congenital dislocation of hip, subluxation and dysplasia]. Beitr Orthop Traumatol. 1968;15(11):700-1. German. PubMed PMID: 5733049.
138: Ranft G, Cerwenka W. [Pediatric-orthopedic cooperation for early diagnosis and treatment of hip dysplasia]. Beitr Orthop Traumatol. 1967 Jun;14(6):336-40. German. PubMed PMID: 5588864.
139: Krumi≈Ñ KA. [Priniciples of early diagnosis and treatment of congenital dysplasia of the hip]. Chir Narzadow Ruchu Ortop Pol. 1967;32(5):627-9. Polish. PubMed PMID: 6065739.
140: Goncharov NT. [Our experience in the early diagnosis and treatment of congenital dysplasia of the hip joint]. Ortop Travmatol Protez. 1966 Aug;27(8):24-8. Russian. PubMed PMID: 5993891.
141: Conlin FD. Congenital hip. Rev Clin Inst Matern Lisb. 1965 Jul-Dec;16(62):939. PubMed PMID: 5898984.
142: Zwierzchowski H. [A contribution to diagnosis of congenital dysplasia of the hip with subluxation]. Chir Narzadow Ruchu Ortop Pol. 1965;30(6):653-4. Polish. PubMed PMID: 5863710.
143: IMADA H, KATO D, ISHIGAKI M. [RESULTS OF A 6-YEAR STUDY TO PREVENT CONGENITAL HIP DISLOCATION.]. Nippon Seikeigeka Gakkai Zasshi. 1964 Sep;38:567-9. Japanese. PubMed PMID: 14216566.
144: BOBIC R. [ON THE PROBLEM OF HIP DYSPLASIA.]. Zdrav Vestn. 1964;33:160-4. Undetermined Language. PubMed PMID: 14313157.
145: HERCZEGH M. [Screening tests in congenital hip dislocation.]. Orv Hetil. 1962 Jun 17;103:1128-31. Hungarian. PubMed PMID: 13906658.